Nephrocalcinosis in very low birth weight infants
- PMID: 20228514
Nephrocalcinosis in very low birth weight infants
Abstract
To determine the incidence and risk factors of nephrocalcinosis in preterm infants, we studied in a prospectively 64 preterm infants of birth weight :5 1500 g from February 2006 to November 2007. Data were collected on gestation, birth weight, gender and family history of renal calculi, respiratory support, and use of nephrotoxic drugs. The parameters of mineral metabolism were assessed in blood and spot urine samples at the end of 2 nd and 4 th weeks of age. Forty-nine babies completed the study, and nephrocalcinosis was observed in 13 (26.5%) babies and was bilateral in 7 (14.3%) infants. The mean age of diagnosis of nephrocalcinosis was 52.58 days (range 30-123 days). Gestational age, birth weight, and sex were not significantly associated with increased risk of nephrocalcinosis. The mean duration of ventilation was significantly less in babies with than without nephrocalcinosis (P= 0.020), and the mean levels of urine calcium and phosphate at 4 weeks of age, respectively (P= 0.013, P= 0.048). There were also significant differences in urine calcium/creatinine ratio (P= 0.001), mean plasma levels of calcium at 2 weeks of age (P= 0.047) and plasma levels of phosphate at 4 weeks of age (P= 0.016) between babies with and without nephrocalcinosis. Using logistic regression analysis, family history of renal stone (P= 0.002) and urine calcium/creatinine ratio (P= 0.011) were significant predictors of nephrocalcinosis. However, there were no significant differences in the length of stay in the intensive care unit, duration of total parenteral nutrition, and duration and cumulative doses of nephrotoxic drugs between these two groups. We conclude that the incidence of nephrocalcinosis was similar in our population to the previous studies. Family history of renal stone and urine calcium/ creatinine ratio are the major risk factors of nephrocalcinosis in very low birth weight neonates.
Similar articles
-
Nephrocalcinosis in preterm babies.Arch Dis Child Fetal Neonatal Ed. 2001 Nov;85(3):F207-13. doi: 10.1136/fn.85.3.f207. Arch Dis Child Fetal Neonatal Ed. 2001. PMID: 11668166 Free PMC article.
-
Urinary citrate in preterm and term babies.Early Hum Dev. 2005 Apr;81(4):319-23. doi: 10.1016/j.earlhumdev.2004.07.007. Epub 2004 Oct 22. Early Hum Dev. 2005. PMID: 15814215
-
Development of nephrocalcinosis in very low birth weight infants.Pediatr Nephrol. 2004 Jun;19(6):616-20. doi: 10.1007/s00467-004-1428-x. Epub 2004 Mar 31. Pediatr Nephrol. 2004. PMID: 15054644
-
Nephrocalcinosis in preterm neonates.Pediatr Nephrol. 2010 Feb;25(2):221-30. doi: 10.1007/s00467-008-0908-9. Epub 2008 Sep 17. Pediatr Nephrol. 2010. PMID: 18797936 Free PMC article. Review.
-
Nephrocalcinosis in Neonates.Neoreviews. 2024 Feb 1;25(2):e88-e98. doi: 10.1542/neo.25-2-e88. Neoreviews. 2024. PMID: 38296790 Review.
Cited by
-
The effects of low and high dose oral calcium and phosphor supplementation on nephrocalcinosis diagnosed by sonography in premature and low birth weight neonates.Iran J Med Sci. 2014 Nov;39(6):559-64. Iran J Med Sci. 2014. PMID: 25429179 Free PMC article.
-
Clinical pharmacology of furosemide in neonates: a review.Pharmaceuticals (Basel). 2013 Sep 5;6(9):1094-129. doi: 10.3390/ph6091094. Pharmaceuticals (Basel). 2013. PMID: 24276421 Free PMC article.
-
Nephrocalcinosis in very low birth weight infants: incidence, associated factors, and natural course.Pediatr Nephrol. 2022 Dec;37(12):3093-3104. doi: 10.1007/s00467-021-05417-w. Epub 2022 Mar 28. Pediatr Nephrol. 2022. PMID: 35348900 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources